Navigation Links
American Brain Tumor Association and Cleveland Clinic Conference Offers Continuing Education to Health Care Professionals
Date:9/24/2013

Chicago, IL (PRWEB) September 24, 2013

The American Brain Tumor Association (ABTA), in joint sponsorship with Cleveland Clinic, will present the 15th Annual Brain Tumor Update and 4th Annual International Symposium on Long-term Control of Metastases to the Brain and Spine on Saturday, Nov. 9 and Sunday, Nov. 10 at the Bellagio Hotel in Las Vegas.

The first day of the conference will feature a new “Partners in Care” track developed by the ABTA specifically for nurses, social workers and physicians seeking to advance their knowledge of issues that directly impact brain tumor patients and their families. The track will address the care of patients with either metastatic or primary brain tumors.

Recently, the ABTA conducted an extensive survey of health care professionals from across the United States, the results of which informed the development of the “Partners in Care” conference track.

“Professional development is an important part of helping to move the brain tumor field forward, and health care professionals turn to the ABTA as a trusted resource,” says Mary Lovely, PhD, ABTA senior advisor, Mission Division, and course co-director. “Our recent needs assessment showed that the vast majority of health care professionals seek information about brain tumors, not only to assist patients, but also to increase their personal knowledge. And by far, their most preferred method of learning is the professional conference setting. In partnering with Cleveland Clinic, the ABTA can provide an important, sought-after educational opportunity to health care professionals who are interacting with patients and families every day.”

The “Partners in Care” session will identify specific, practical strategies for living with a brain tumor including symptom management, caregiver needs, palliative care and the financial aspects of brain tumor care. Nationally recognized experts will provide overviews of cerebral functions affected by brain tumors, common tumor types and treatments, assessing cognition changes, the management of fatigue and financial resources.

The second day of the conference will offer all attendees an opportunity to learn about updates in management of unusual tumors, advancements in the treatment of gliomas, new surgical techniques and more.

Individuals can choose to attend one or both days. For the full conference program and registration information, visit http://www.ccfcme.org/BrainMets13.

This activity has been approved for AMA PRA Category 1 Credits™. Continuing Education Units are available for nurses. This activity is pending approval from the National Association of Social Workers.

ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION

Founded in 1973, the American Brain Tumor Association was the first and is now the only national organization committed to funding brain tumor research and providing support and education programs for all tumor types and all age groups. For more information, visit http://www.abta.org.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11156139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Clinical news alert from the American Academy of Orthopaedic Surgeons
2. American College of Cardiology cites new USF Simulation Center for Training Excellence
3. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
4. Young Americans Need to Cut Calorie Intake: Study
5. Hutchinson Center president elected to American Academy of Art and Sciences
6. Can weight loss help African-American breast cancer survivors?
7. Americans Support Medicare Reform, But Not on Their Dime: Poll
8. One-third of adult Americans with arthritis battle anxiety or depression
9. Equal access to care helps close survival gap for young African-American cancer patients
10. Systemic sclerosis complications more severe in African Americans than Caucasians
11. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching of ... Unified Instance Manager architecture, meeting the needs of multichannel growth and doubling ... unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... surgery as possible. With this in mind, SIGVARIS has created a new line ... clot) during bed rest and provide the benefits of graduated compression when transitioning ...
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
(Date:12/8/2016)... 8, 2016 Global Interventional Radiology Market: ... global interventional radiology market analyzes the current and ... an elaborate executive summary, including a market snapshot ... sub-segments. The research is a combination of ... bulk of our research efforts along with information ...
(Date:12/8/2016)... -- Eli Lilly and Company (NYSE: LLY ) ... trial at the 9 th Clinical Trials on ... not meet the primary endpoint in the EXPEDITION3 clinical ... mild dementia due to Alzheimer,s disease (AD), and Lilly ... treatment of mild dementia due to AD. ...
Breaking Medicine Technology: